Literature DB >> 8227304

Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level.

J Bauer1, F Berkenbosch, A M Van Dam, C D Dijkstra.   

Abstract

Interleukin-1 beta (IL-1) is a cytokine which exerts many biological effects during inflammation. In the present study, experimental allergic encephalomyelitis (EAE) was induced in Lewis rats. During the various stages of EAE, the presence of IL-1 in the brain was investigated using immunocytochemistry at both the light and ultrastructural level. Ten days after immunization, IL-1 immunoreactivity was found in brains of animals which at this time showed mild clinical signs. Outside the blood-brain barrier, IL-1 was localized in the cytoplasm of meningeal macrophages and perivascular cells. Within the brain parenchyma, IL-1 immunoreactivity was distributed in perivascular lesions in the cytoplasm of infiltrated macrophages and activated microglia. On day 13, animals had developed a full blown EAE. At this stage the number of lesions with IL-1-positive cells had increased. In the remission phase (day 25), lesions with IL-1-positive cells could still be detected but were less pronounced as compared to day 13. Other presumptive IL-1-producing cell types like endothelial cells or astrocytes were, at none of the various stages, found to stain for IL-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227304     DOI: 10.1016/0165-5728(93)90053-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  32 in total

1.  Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.

Authors:  S Hisahara; T Araki; F Sugiyama; K i Yagami; M Suzuki; K Abe; K Yamamura; J Miyazaki; T Momoi; T Saruta; C C Bernard; H Okano; M Miura
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 2.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

3.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

4.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

Authors:  S R Ruuls; S Van Der Linden; K Sontrop; I Huitinga; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

5.  Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat.

Authors:  I Huitinga; J Bauer; P J Strijbos; N J Rothwell; C D Dijkstra; F J Tilders
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 6.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

7.  Interleukin-1beta promotes repair of the CNS.

Authors:  J L Mason; K Suzuki; D D Chaplin; G K Matsushima
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 8.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

9.  Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.

Authors:  Georgia Mandolesi; Alessandra Musella; Antonietta Gentile; Giorgio Grasselli; Nabila Haji; Helena Sepman; Diego Fresegna; Silvia Bullitta; Francesca De Vito; Gabriele Musumeci; Claudio Di Sanza; Piergiorgio Strata; Diego Centonze
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

Review 10.  Parkinson's disease and inflammatory changes.

Authors:  Carlos Barcia; Andrés Fernández Barreiro; Máximo Poza; María-Trinidad Herrero
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.